ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,048,000 | -9.1% | 164,700 | 0.0% | 0.06% | +13.2% |
| Q3 2016 | $2,254,000 | +21.9% | 164,700 | -34.2% | 0.05% | +15.2% |
| Q2 2016 | $1,849,000 | +15.6% | 250,300 | 0.0% | 0.05% | +27.8% |
| Q1 2016 | $1,599,000 | +128.1% | 250,300 | +122.9% | 0.04% | +140.0% |
| Q4 2015 | $701,000 | +7.0% | 112,300 | 0.0% | 0.02% | -16.7% |
| Q3 2015 | $655,000 | -29.4% | 112,300 | 0.0% | 0.02% | -5.3% |
| Q2 2015 | $928,000 | +0.3% | 112,300 | 0.0% | 0.02% | +5.6% |
| Q1 2015 | $925,000 | +20.0% | 112,300 | 0.0% | 0.02% | +20.0% |
| Q4 2014 | $771,000 | +27.2% | 112,300 | 0.0% | 0.02% | +25.0% |
| Q3 2014 | $606,000 | -15.2% | 112,300 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $715,000 | -21.0% | 112,300 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $905,000 | +18.3% | 112,300 | 0.0% | 0.02% | +23.1% |
| Q4 2013 | $765,000 | -20.5% | 112,300 | +114.7% | 0.01% | -27.8% |
| Q3 2013 | $962,000 | +5.3% | 52,300 | 0.0% | 0.02% | +5.9% |
| Q2 2013 | $914,000 | – | 52,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |